Literature DB >> 11275647

Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia.

X Wang1, J O Karlsson, C Zhu, B A Bahr, H Hagberg, K Blomgren.   

Abstract

Caspase-3 is a major effector protease in several apoptotic pathways, but its role in hypoxic-ischemic (HI) brain injury is incompletely understood. Cerebral HI was induced in 7-day-old rats by unilateral carotid artery ligation and exposure to 7.7% oxygen for 55 min. Caspase-3-like activity was significantly increased at 1 h (208%), peaked at 24 h (2,563%) and was still increased 6 days after HI (169%) in the ipsilateral cerebral cortex. Concomitantly, cleavage of the caspase-3 proform (31/33 kD) was detected on immunoblots, producing 29- and 17-kD fragments. Furthermore, significant degradation of the endogenous caspase-3 substrates inhibitor of caspase-activated DNase (DNA fragmentation factor 45), poly(ADP-ribose) polymerase and fodrin occurred. In conclusion, caspase-3 is activated extensively in the immature brain after HI. The subsequent cleavage of proteins involved in cellular homeostasis and repair may contribute to the process of brain injury. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275647     DOI: 10.1159/000047087

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  38 in total

Review 1.  Endoplasmic reticulum stress, inflammation, and perinatal brain damage.

Authors:  Wolfgang Bueter; Olaf Dammann; Alan Leviton
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

2.  Effects of progesterone on the neonatal brain following hypoxia-ischemia.

Authors:  Rafael Bandeira Fabres; Luciana Abreu da Rosa; Samir Khal de Souza; Ana Lucia Cecconello; Amanda Stapenhorst Azambuja; Eduardo Farias Sanches; Maria Flavia Marques Ribeiro; Luciano Stürmer de Fraga
Journal:  Metab Brain Dis       Date:  2018-01-23       Impact factor: 3.584

3.  (-)-Epigallocatechin-3-gallate protects against neuronal cell death and improves cerebral function after traumatic brain injury in rats.

Authors:  Tatsuki Itoh; Motohiro Imano; Shozo Nishida; Masahiro Tsubaki; Shigeo Hashimoto; Akihiko Ito; Takao Satou
Journal:  Neuromolecular Med       Date:  2011-10-25       Impact factor: 3.843

Review 4.  Systemic prenatal insults disrupt telencephalon development: implications for potential interventions.

Authors:  Shenandoah Robinson
Journal:  Epilepsy Behav       Date:  2005-08-02       Impact factor: 2.937

5.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 6.  Hypoxic-ischemic encephalopathy in the term infant.

Authors:  Ali Fatemi; Mary Ann Wilson; Michael V Johnston
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

7.  Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats.

Authors:  Tatsuki Itoh; Takao Satou; Shozo Nishida; Masahiro Tsubaki; Motohiro Imano; Shigeo Hashimoto; Hiroyuki Ito
Journal:  Neurochem Res       Date:  2009-09-19       Impact factor: 3.996

8.  Differential activation of c-fos and caspase-3 in hippocampal neuron subpopulations following neonatal hypoxia-ischemia.

Authors:  Jayne M Ness; Cary R Harvey; Jason D Washington; Kevin A Roth; Steven L Carroll; Jianhua Zhang
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

Review 9.  Mitochondrial impairment in the developing brain after hypoxia-ischemia.

Authors:  Henrik Hagberg
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Unilateral blood flow decrease induces bilateral and symmetric responses in the immature brain.

Authors:  Sonia Villapol; Philippe Bonnin; Sébastien Fau; Olivier Baud; Sylvain Renolleau; Christiane Charriaut-Marlangue
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.